What to watch

No items found.

Week of

June 3rd

2024

Week in review

GSK acquires RNA startup Elsie to boost RNA drug development

‍

Bristol Myers Squibb's Opdivo and Yervoy combo could become the new standard of care for liver cancer

Boehringer Ingelheim's Survodutide proves effective in treating liver fibrosis

Novo Nordisk highlights the power of Wegovy in new campaign

‍

AstraZeneca's lung cancer drug, Tagrisso, shows remarkable efficacy

‍

NHS platform will accelerate personalised cancer vaccine clinical trials

‍

A new type of immunotherapy has demonstrated promising results in treating bone cancer

‍

FDA raises concerns about Eli Lilly's Alzheimer's drug

‍

American Cancer Society (ACS) reports that LGBTQ+ populations may have a higher risk of cancer

‍

First male contraceptive proves to be safe for men

‍

HIV drug, Daraprim, prices remain high nine years after Shkreli controversy

‍